MetLife Investment Advisors »

Syndax Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $751k 35k 21.61
2023-09-30 $505k 35k 14.52
2023-06-30 $727k 35k 20.93
2023-03-31 $668k 32k 21.12
2022-12-31 $711k 28k 25.45
2022-09-30 $650k 27k 24.03
2022-06-30 $520k 27k 19.24
2022-03-31 $470k 27k 17.39
2021-12-31 $373k 17k 21.87
2021-09-30 $326k 17k 19.11
2021-06-30 $293k 17k 17.17
2021-03-31 $251k 11k 22.38
2020-12-31 $249k 11k 22.20
2020-09-30 $166k 11k 14.80
2020-06-30 $166k 11k 14.80
2020-03-31 $123k 11k 10.97